Moon Heewon, Lee Sookyoung, Huh Jungwon, Chung Wha Soon
Department of Laboratory Medicine, School of Medicine, Ewha Womans University, Seoul, Korea.
Korean J Lab Med. 2007 Oct;27(5):313-7. doi: 10.3343/kjlm.2007.27.5.313.
HLA-DR negativity is known to be useful for distinguishing acute promyelocytic leukemia (APL) from other subtypes of AML, but non-APL cases without HLA-DR antigen expression have been reported. The purpose of this study was to evaluate and compare the characteristics of APL, HLA-DR negative non-APL, and HLA-DR positive non-APL cases.
A total of 114 cases of AML admitted at Ewha Womans University, Mokdong Hospital between March 1997 and June 2006 were included in this study. A diagnosis of AML was made based on the results of morphology, cytochemistry, immunophenotype, cytogenetics, and/or fluorescence in situ hybridization.
Among the 114 AML patients, HLA-DR antigen was not expressed in 39 (34%), including 24 non-APL (62%) and 15 APL patients (38%). The HLA-DR negative non-APL group showed higher leukocyte counts and positive rate of CD19 expression than did APL group (P<0.05). The remaining laboratory findings were not statistically different between the HLA-DR negative non-APL and APL groups. CD34 expression was more frequent in the HLA-DR positive non-APL group than in the HLA-DR negative non-APL group and APL group. Of the 24 patients with HLA-DR negative non-APL, 7 patients had disseminated intravascular coagulation and 2 patients showed morphologic features similar to those of APL.
CD19 expression and leukocyte count may be helpful for differentiating HLA-DR negative non-APL from APL. However, the final diagnosis and classification should be confirmed by cytogenetic or molecular studies.
已知HLA - DR阴性有助于将急性早幼粒细胞白血病(APL)与急性髓系白血病(AML)的其他亚型区分开来,但已有报道称存在无HLA - DR抗原表达的非APL病例。本研究的目的是评估和比较APL、HLA - DR阴性非APL以及HLA - DR阳性非APL病例的特征。
本研究纳入了1997年3月至2006年6月在梨花女子大学木洞医院收治的114例AML病例。根据形态学、细胞化学、免疫表型、细胞遗传学和/或荧光原位杂交结果做出AML诊断。
在114例AML患者中,39例(34%)未表达HLA - DR抗原,其中包括24例非APL(62%)和15例APL患者(38%)。HLA - DR阴性非APL组的白细胞计数和CD19表达阳性率高于APL组(P<0.05)。HLA - DR阴性非APL组与APL组之间其余实验室检查结果无统计学差异。HLA - DR阳性非APL组中CD34表达比HLA - DR阴性非APL组和APL组更常见。在24例HLA - DR阴性非APL患者中,7例发生弥散性血管内凝血,2例表现出与APL相似的形态学特征。
CD19表达和白细胞计数可能有助于区分HLA - DR阴性非APL与APL。然而,最终诊断和分类应通过细胞遗传学或分子研究来确认。